Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Webinar on research opportunities post COVID-19 organised by Alpine College of Management and…
Prof (Dr) B Suresh, President, Pharmacy Council of India attended the webinar as a guest speaker
How start-ups and businesses can protect their unique selling proposition
Simranjeet Singh, Partner and Aadhar Nautiyal, Associate, Athena Legal reason that it is imperative for start-ups and businesses…
India’s only certified TB Bacteria and H1N1 Virus disinfectant formulation now hits the retail…
The disinfectant is also effective against the family of coronaviruses
Te Herenga Waka—Victoria University, NZ professor receives funding boost for vaccine research
Associate Professor Stocker has received $596,504 over two years from the Health Research Council of New Zealand to continue her…
Indian pharma companies looking to leverage opportunities in drug repurposing: GlobalData
In race for favipiravir clinical trials for COVID-19
Jubilant Life Sciences posts Rs 260.49 cr profit for Jan-Mar
Inspite of challenges, pharma biz segment growth likely to be healthy: ICICI Securities
Gilead’s remdesivir shows modest improvement in moderate COVID-19 patients
Remdesivir, which is administered intravenously in hospital, is the first drug to show improvement in COVID-19 patients in formal…
Russia to roll out its first approved COVID-19 drug next week
Russian hospitals can begin giving the antiviral drug, which is registered under the name Avifavir, to patients from June 11, the…
Enterprise Ireland promotes Abhinav Bhatia as its new Director- India & South Asia
Bhatia is the first Indian to hold this position
Psoriasis digital landscape for patients in Japan offers competent patient engagement: says…
According to GlobalData’s Epidemiology and Market Size Database, the value of the plaque psoriasis market in Japan is estimated to…